Double Medical Technology Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Jiong Luo
Chief executive officer
CN¥1.5m
Total compensation
CEO salary percentage | n/a |
CEO tenure | no data |
CEO ownership | 0.06% |
Management average tenure | 9.2yrs |
Board average tenure | 6yrs |
Recent management updates
Recent updates
Double Medical Technology Inc. (SZSE:002901) Not Lagging Industry On Growth Or Pricing
Jan 08There Are Reasons To Feel Uneasy About Double Medical Technology's (SZSE:002901) Returns On Capital
Dec 18Market Participants Recognise Double Medical Technology Inc.'s (SZSE:002901) Revenues Pushing Shares 29% Higher
Oct 01Is Double Medical Technology (SZSE:002901) A Risky Investment?
Sep 27Capital Allocation Trends At Double Medical Technology (SZSE:002901) Aren't Ideal
Sep 05Double Medical Technology (SZSE:002901) Seems To Use Debt Quite Sensibly
Jun 19Investors Could Be Concerned With Double Medical Technology's (SZSE:002901) Returns On Capital
May 28CEO
Jiong Luo (56 yo)
no data
Tenure
CN¥1,456,800
Compensation
Mr. Jiong Luo serves as General Manager and Director of Double Medical Technology Inc. Mr. Luo served as General Manager of China Region of Xin Di Si (Shanghai) Medical Device Trading Company Limited from...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
GM & Director | no data | CN¥1.46m | 0.064% CN¥ 9.1m | |
Administrative Director | 9.2yrs | CN¥525.90k | 0.0056% CN¥ 797.9k | |
R & D Director | 9.2yrs | CN¥672.10k | 0.0049% CN¥ 706.2k | |
Financial Director & Accounting Supervisor | 1.4yrs | no data | no data | |
Board Secretary | no data | no data | no data |
9.2yrs
Average Tenure
47.5yo
Average Age
Experienced Management: 002901's management team is seasoned and experienced (9.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
GM & Director | no data | CN¥1.46m | 0.064% CN¥ 9.1m | |
Chairman of Board of Directors | no data | CN¥508.80k | 85.09% CN¥ 12.2b | |
Vice Chairman | no data | CN¥491.00k | no data | |
Director | 9.2yrs | no data | no data | |
Chairman of Supervisory Board | no data | no data | 0.0018% CN¥ 263.6k | |
Member of Supervisory Board | 9.3yrs | no data | no data | |
Employee Representative Member of Supervisory Board | no data | no data | no data | |
Independent Director | 6yrs | CN¥80.00k | no data | |
Independent Director | 6yrs | CN¥80.00k | no data | |
Independent Director | 2.3yrs | CN¥80.00k | no data |
6.0yrs
Average Tenure
49.5yo
Average Age
Experienced Board: 002901's board of directors are considered experienced (6 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/31 02:30 |
End of Day Share Price | 2025/01/27 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Double Medical Technology Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Zhu Chen | Citic Securities Co., Ltd. |
Shuo Song | Citic Securities Co., Ltd. |
Song Yang | Tianfeng Securities Brokerage Co., Ltd |